Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.72 USD | -1.79% | -6.49% | -85.32% |
Mar. 15 | Maxim Group Adjusts Quoin Pharmaceuticals Price Target to $4 From $15, Maintains Buy Rating | MT |
Mar. 14 | Quoin Pharmaceuticals Seeks M&A Opportunities | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-85.32% | 2.65M | |
-1.82% | 41.35B | |
+41.98% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- QNRX Stock
- News Quoin Pharmaceuticals, Ltd.
- Quoin Pharmaceuticals Signs License Agreement With Genpharm for Genetic Disease Drug Candidate